Smith & Nephew Tops European M&A Targets for Second Year in Row

  • ITV, Syngenta came in second in Bloomberg survey of analysts
  • M&A spending broke records to reach all-time-high in 2015

Smith & Nephew Plc, the British maker of replacement knee joints and medical devices, is the top European acquisition target for the second year in a row in a Bloomberg survey of traders and analysts.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.